sb 202190 has been researched along with Bone Cancer in 1 studies
4-(4-fluorophenyl)-2-(4-hydroxyphenyl)-5-(4-pyridyl)imidazole: structure given in first source; inhibits p38 MAP kinase
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Rachner, TD | 1 |
| Göbel, A | 1 |
| Browne, A | 1 |
| Hötzel, J | 1 |
| Rauner, M | 1 |
| Hofbauer, LC | 1 |
1 other study available for sb 202190 and Bone Cancer
| Article | Year |
|---|---|
P38 regulates the Wnt inhibitor Dickkopf-1 in breast cancer.
Topics: Bone Neoplasms; Breast Neoplasms; Cell Line, Tumor; Female; Humans; Imidazoles; Intercellular Signal | 2015 |